Hemoglobinopathy Carrier Prevalence in The United Arab Emirates: First Analysis of The Dubai Health Authority Premarital Screening Program Results
- 18 April 2013
- journal article
- Published by Taylor & Francis in Hemoglobin
- Vol. 37 (4) , 359-368
Abstract
The aim of this study was to determine the prevalence of hemoglobinopathy carriers in United Arab Emirates (UAE) nationals subjected to mandatory premarital screening in Dubai over a 4-year period. Data from UAE nationals who underwent premarital screening by the Dubai Health Authority between January 2007 and December 2010 were collected and analyzed. Premarital screening in Dubai is based on complete blood counts (CBC) and hemoglobin (Hb) high performance liquid chromatography (HPLC). Among the 6,420 UAE nationals screened, 8.5% (n = 545) were suspected to be carriers. The following carrier frequencies were observed: β-thalassemia (β-thal), 4.56% (n = 293); Hb S [β6(A3)Glu→Val, GAG>GTG; HBB: c.20A>T], 2.9% (n = 186); Hb D-Punjab [β121(GH4)Glu→Gln, GAA>CAA; HBB: c.364G>C], 0.78% (n = 50); Hb Lepore (δβ hybrid gene) with an undetermined molecular genotype, 0.17% (n = 11); Hb E [β26(B8)Glu→Lys, GAG>AAG; HBB: c.79G>A], 0.03% (n = 2); and hereditary persistence of fetal Hb (HPFH), 0.016% (n = 1). Hb E-Hb S and Hb E-β-thal also occurred at a rate of 0.016% (n = 1) each; and 0.87% (n = 56) subjects were suspected of carrying silent β-thal. The prevalence of β-thal trait was consistent with the prevalence published by others in the region. Silent β-thal is challenging for screening programs, and is expected to arise in populations with a high prevalence of β-thal carriers. The prevalence of Hb S trait observed in this study was lower than that in other reports for the region. New cases of β-thal major (β-TM) still arise because many fertile couples got married before the screening programs were implemented, and pregnancy termination is not widely practiced in the UAE due to religious restraints. Moreover, some couples choose not to have prenatal diagnosis (PND) or pre implantation genetic diagnosis (PGD), even if they are aware of their risk status. The prevalence of β-thal trait in the UAE is high. This justifies efforts to control the disease by holding regular community awareness and screening programs, performing premarital screening and genetic counseling, and making PND and PGD available to couples who request it.Keywords
This publication has 27 references indexed in Scilit:
- Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi ArabiaAnnals of Saudi Medicine, 2011
- PREMARITAL SCREENING TEST RESULTS FOR β-THALASSEMIA AND SICKLE CELL ANEMIA TRAIT IN EAST MEDITERRANEAN REGION OF TURKEYPediatric Hematology and Oncology, 2010
- Carrier screening for Beta-thalassaemia: a review of international practiceEuropean Journal of Human Genetics, 2010
- Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi‐ethnic populationsInternational Journal of Laboratory Hematology, 2009
- Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in IndiaPrenatal Diagnosis, 2008
- Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of -thalassemiaHaematologica, 2008
- Carrier Screening and Prenatal Diagnosis of Hemoglobinopathies. A Study of Indigenous and Immigrant Couples in Northern Greece, Over the Last 5 YearsHemoglobin, 2008
- Prevalence of Beta-thalassemia and Sickle Cell Anemia Trait in Premarital Screening in Konya Urban Area, TurkeyJournal of Pediatric Hematology/Oncology, 2007
- Iranian national thalassaemia screening programmeBMJ, 2004
- Population genetic screening programmes: principles, techniques, practices, and policiesEuropean Journal of Human Genetics, 2003